MSANTD3-TMEFF1

Across TCGA pan-cancer cohorts, MSANTD3-TMEFF1 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated MSANTD3-TMEFF1 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher MSANTD3-TMEFF1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MSANTD3-TMEFF1 expression acts as an unfavorable survival marker, although some lineages such as KIRC and UCEC show a favorable association.

MESO, CESC, and BLCA are the cancer types where MSANTD3-TMEFF1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	All	0.258	0.502	.001	120	view →
CESC	DFS	Median	All	0.423	0.664	<.001	106	view →
BLCA	OS	Median	All	0.532	0.674	<.001	67	view →
LUAD	OS	Quartile	All	0.199	0.451	<.001	41	view →
KIRP	DFS	Median	IV	0.036	0.528	.001	41	view →
KIRC	DFS	Median	All	0.872	0.716	<.001	38	view →
UCEC	DFS	Tertile	IV	0.883	0.606	.012	26	view →
COAD	DFS	Quartile	All	0.445	0.749	.007	23	view →
UVM	DFS	Tertile	III,IV	0.295	0.862	.005	22	view →
LUSC	OS	Median	III,IV	0.435	0.685	.004	19	view →
PAAD	OS	Tertile	All	0.324	0.577	.024	18	view →
STAD	DFS	Median	All	0.610	0.461	.014	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

MSANTD3-TMEFF1–MESO (OS)

Open the MESO breakdown →